Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

Diagnosis of Alzheimer's Disease Severity with fMRI Images Using Robust Multitask Feature Extraction Method and Convolutional Neural Network (CNN)

A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction

Enhancing Alzheimer's disease diagnosis and staging: a multistage CNN framework using MRI

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Brain MRI Analysis for Alzheimer’s Disease Diagnosis Using CNN-Based Feature Extraction and Machine Learning

Diagnosis and classification of Alzheimer's disease by using a convolution neural network algorithm

Alzheimer's MRI Recognition Based on Convolutional Neural Networks

Diagnosis of Alzheimer’s Disease Via Multi-Modality 3D Convolutional Neural Network

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

Diagnosis of Alzheimer's Disease via Multi-modality 3D Convolutional Neural Network

Early diagnosis of Alzheimer's disease from MRI images with deep learning model

Deep Convolution Neural Network Based System for Early Diagnosis of Alzheimer's Disease

An NCA-based Hybrid CNN Model for Classification of Alzheimer’s Disease on Grad-CAM-enhanced Brain MRI Images

Automated Classification of Alzheimer’s Disease Based on MRI Image Processing using Convolutional Neural Network (CNN) with AlexNet Architecture

Automated classification of Alzheimer's disease, mild cognitive impairment, and cognitively normal patients using 3D convolutional neural network and radiomic features from T1-weighted brain MRI: A comparative study on detection accuracy

Temporal and Spatial Analysis of Alzheimer’s Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network

A novel CNN architecture for accurate early detection and classification of Alzheimer's disease using MRI data

Classification of Subjects of Mild Cognitive Impairment and Alzheimer’s Disease Through Neuroimaging Modalities and Convolutional Neural Networks

Dual Attention Convolutional AutoEncoder for Diagnosis of Alzheimer's Disorder in Patients Using Neuroimaging and MRI Features

Attention-based 3D CNN with Multi-layer Features for Alzheimer's Disease Diagnosis using Brain Images

Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer’s Disease Diagnosis